fbpx

Be Iconic, Beyond Limits: J.F. Rey Marks 40 Years of Bold Eyewear Innovation

JF Rey image campagne sept 2025 et logo 40 ans

French eyewear brand J.F. Rey is celebrating its 40th anniversary, reaffirming the values that have defined its journey: independent creativity, excellence in craftsmanship, and a bold, unmistakable style that has become a global eyewear icon.

From its beginnings, J.F. Rey has embraced a singular vision—free from convention and unapologetically daring. Four decades later, that spirit continues to drive the brand’s innovation and shape its identity. The latest anniversary collection represents the culmination of this creative heritage, designed to resonate with today’s high-end market while staying true to its roots.

The new collection spans men’s, women’s, optical, and sun lines, each with a distinct personality defined by signature aesthetics and exclusive technologies. The designs balance technical mastery and striking visual identity, offering a fresh evolution of J.F. Rey’s iconic forms.

Among the highlights:

  • SLEDGE series – A showcase of masculine excellence, with bold lines, uncompromising strength, and patented screwless hinges.
  • Women’s models – More sensitive, accessible, and versatile, featuring gradient effects that introduce a fresh chromatic signature for the season.
  • CARBON INSIDE line – A creative breakthrough with unprecedented coloring of select wood veneers, blending natural materials with avant-garde design.

Color remains central to the brand’s DNA, with deep autumnal shades, metallic effects, and original contrasts adding richness and depth to the collection.

J.F. Rey will present the collection at SILMO Paris (Hall 7 – Booth C129).

👉 More information: jfrey.fr

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

The Vision Council Releases New Report on Myopia Treatment Trends

The Vision Council logo

The Vision Council has released a new two-part research report, Focused inSights 2025: Myopia Management, offering a combined global and U.S. perspective on pediatric myopia treatment. The dual-format report compares regulatory and product availability trends internationally with survey data from U.S. eyecare providers, creating one of the most comprehensive views of current approaches to childhood myopia care.

Comparative Myopia Treatment Strategies

The first section examines treatment availability across the U.S., Canada, the U.K., and the EU, with a focus on four major categories: low-dose atropine drops, myopia control spectacle lenses, multifocal or dual-focus daily soft contact lenses, and orthokeratology.

The report highlights uneven adoption across markets, noting milestones such as the EU’s approval of Ryjunea atropine drops and France’s decision to fully reimburse myopia control spectacle lenses. It also considers financing models and prescribing practices across different regions.

Provider Approaches in the U.S.

The second section presents findings from a survey of 293 U.S. optometrists, practice owners, and managers conducted between June 16 and July 4, 2025. Key insights include:

  • Proactive screening: 91% of providers recommend myopia screenings at least once a year.
  • Treatment adoption: About 70% of providers report offering myopia management to children in their practice.
  • Most common treatment: MiSight® contact lenses are prescribed most frequently (81%).
  • Motivations: Providers cite slowing progression (78%), reducing complication risks (78%), and improving long-term eye health (71%) as leading reasons to treat.
  • Risk factors: Excessive screen time (82%), genetics (82%), and limited outdoor activity (77%) were identified as the main drivers of myopia.
  • Challenges: Cost (86%), parental understanding (56%), and patient compliance (49%) remain significant barriers.

“This dual-format report provides both a global and a local lens on myopia management,” said Alysse Henkel, Vice President of Research and inSights at The Vision Council. “It’s clear that U.S. providers take myopia seriously, but they also face challenges in affordability and patient education. By including an international analysis, we can see where care stands today and where it is headed.”

The full report is available through The Vision Council’s Research Download Center. Members may access the report at no cost; non-members can purchase it for $5,000.

Source: The Vision Council

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Neurolens Rebrands as Newton, Signaling Next Phase of Optical Innovation

Neurolens rebrands as Newton logo

Neurolens, known for developing Contoured Prism™ technology to address binocular vision issues, has officially rebranded as Newton™. The company says the change reflects a strategic evolution and renewed focus on innovation in eye care.

The new name pays homage to Sir Isaac Newton, widely regarded as one of history’s most influential scientists in mathematics, physics, astronomy, and optics. Company leaders say this spirit of discovery aligns with Newton’s mission to challenge conventional standards in optometry and uncover new possibilities in vision care.

From Neurolens to Newton

Neurolens launched over a decade ago following research into how binocular vision impacts the trigeminal nerve, particularly during near vision tasks. Its Contoured Prism technology was designed to help eyes work together more comfortably, alleviating symptoms such as headaches, neck pain, and eye strain.

Clinical studies show that approximately 90% of patients report relief from symptoms related to eye misalignment after wearing Neurolenses. The company has since expanded beyond neurology clinics to serve hundreds of thousands of patients across North America.

A New Era of Innovation

As Newton, the company says it will continue supporting optometry practices while introducing new technologies later this month. “Newton represents more than a rebrand—it signals the next chapter in transforming eye care beyond 20/20,” said Davis Corley, CEO. “We don’t just meet expectations—we set new ones.”

Dr. Evie Lawson, an optometrist in Seattle who prescribes Neurolenses, said the technology has been “practice-changing” for her and life-changing for patients. “Newton represents the next level of innovation in eye care, consistently supporting optometry to deliver optimized patient experiences,” Lawson said.

The rebrand positions Newton as an innovation company focused on redefining eye care through patient-centered outcomes and advanced technologies.

Full announcement: Neurolens Rebrands as Newton – PR Newswire

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Study Finds XIIDRA May Improve Comfort for Symptomatic Contact Lens Wearers

Bausch + Lomb

Results from a new investigator-initiated study suggest that XIIDRA® (lifitegrast ophthalmic solution 5%), a prescription drop approved for dry eye disease, may help reduce end-of-day eye dryness and discomfort among symptomatic contact lens wearers.

The study, conducted at the Centre for Ocular Research & Education (CORE) at the University of Waterloo and published in Clinical Ophthalmology, followed 40 participants over 12 weeks. Participants continued wearing their usual contact lenses while using XIIDRA twice daily.

Key Findings

  • Significant improvement in symptoms: After 12 weeks, median scores for end-of-daydryness and discomfort improved by 61 and 59 points, respectively, on a 100-point scale.
  • Early response: Nearly half of participants reported reduced symptoms after just two weeks of treatment, to the extent they would no longer have met study eligibility.
  • Longer wear time: Comfortable lens wear increased by an average of 2.6 hours (from 6.5 to 9.1 hours), though total wear time did not change.
  • Broad symptom relief: Improvements were noted in burning/stinging, itching, foreign body sensation, light sensitivity, and pain.
  • Safety profile: XIIDRA was generally well tolerated, with only two reports of treatment-related adverse events.

Dr. Marc-Matthias Schulze, principal investigator and senior clinical scientist at CORE, noted that improvements were evident as early as two weeks and continued throughout the study. “Results showed that continued use of XIIDRA further improved symptoms, demonstrating that it may allow contact lens wearers to enjoy their lenses throughout the entire day,” he said.

Study Limitations

The study was single-center, open-label, and lacked a control group. Investigators caution that frequent use of prescription drops compared with occasional use of over-the-counter rewetting drops may have contributed to symptom improvements. As such, findings should be interpreted within the limits of the study design, and no formal conclusions can be drawn.

Background

XIIDRA is approved for the treatment of signs and symptoms of dry eye disease. While over-the-counter rewetting drops often provide only temporary relief for contact lens wearers, this study indicates that XIIDRA may represent an alternative option for those with persistent discomfort.

Source: Bausch + Lomb

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

SILMO Paris 2025: Tech Village Launch Highlights AI and Smart Eyewear

Silmo 2025 THE PLACE TO BE, TO SEE, TO FORESEE

At SILMO Paris 2025, the spotlight will be on the future of optics with the debut of the Tech Village, a new space dedicated entirely to artificial intelligence and smart eyewear.

Building on the success of SILMO Next, the Tech Village is designed as a meeting point between research, technology, and professional practice.

A Forward-looking Program

  • 20 exhibitors including: EssilorLuxottica, ACEP, Chamelo, Lucyd Audio Eyewear, Solos.
  • Exclusive experiences from: Everysight, GETD, Laclarée, My Vision Show, Skugga, Titan, VRAI Learning, Widid.
  • Workshops and talks hosted by: Snapchat, Meta, Google.

A Laboratory of Ideas and Trends

With the launch of the Tech Village, SILMO Paris reinforces its position as a laboratory of innovation, where today’s experiments shape tomorrow’s optical industry.

Source : SILMO Paris

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Featured Posts

Zeiss light 2 lenses

ZEISS Light 2 Facilitates Entry into Progressive and Digital Lenses

ZEISS introduces Light 2 progressive and digital lenses—easy to adapt, mid-price, and designed for modern visual demands. New upselling options for ECPs.

Learn More
EssilorLuxottica

EssilorLuxottica Creates Scientific Advisory Committee to Cccelerate Next Era of Innovation

EssilorLuxottica forms a new Scientific Advisory Committee of global experts to guide innovation in ophthalmology, AI, audiology, and life sciences.

Read more
MIDO logo

MIDO 2026 Exhibitor List Now Live as “The Lens of Time” Exhibition Debuts

MIDO 2026 unveils its exhibitor list and debuts “The Lens of Time,” with 1,200 exhibitors, new installations, and expanded event programming.

Read more
World Council of Optometry

WCO Announces 2025 Election Results and New Global Leadership

The World Council of Optometry announces its 2025 election results and new leadership appointments, shaping the next phase of global optometric advocacy.

Read more
University Waterloo School of Optometry

WEI 2025: Education, Innovation, and Connection

The WEI Conference returns November 7–9, 2025 at the Hilton Toronto/Markham Suites with over 20 hours of COPE-accredited CE, the Woodruff and Bobier Distinguished Lectures, a strong speaker lineup, and a trade show featuring 30+ exhibitors — including VuePoint IDS at Booth #311.

Read more
Zeiss light 2 lenses

ZEISS Light 2 Facilitates Entry into Progressive and Digital Lenses

ZEISS introduces Light 2 progressive and digital lenses—easy to adapt, mid-price, and designed for modern visual demands. New upselling options for ECPs.

Learn More
EssilorLuxottica

EssilorLuxottica Creates Scientific Advisory Committee to Cccelerate Next Era of Innovation

EssilorLuxottica forms a new Scientific Advisory Committee of global experts to guide innovation in ophthalmology, AI, audiology, and life sciences.

Read More
MIDO logo

MIDO 2026 Exhibitor List Now Live as “The Lens of Time” Exhibition Debuts

MIDO 2026 unveils its exhibitor list and debuts “The Lens of Time,” with 1,200 exhibitors, new installations, and expanded event programming.

Read More
World Council of Optometry

WCO Announces 2025 Election Results and New Global Leadership

The World Council of Optometry announces its 2025 election results and new leadership appointments, shaping the next phase of global optometric advocacy.

Read More
University Waterloo School of Optometry

WEI 2025: Education, Innovation, and Connection

The WEI Conference returns November 7–9, 2025 at the Hilton Toronto/Markham Suites with over 20 hours of COPE-accredited CE, the Woodruff and Bobier Distinguished Lectures, a strong speaker lineup, and a trade show featuring 30+ exhibitors — including VuePoint IDS at Booth #311.

Read More
Zeiss light 2 lenses

ZEISS Light 2 Facilitates Entry into Progressive and Digital Lenses

ZEISS introduces Light 2 progressive and digital lenses—easy to adapt, mid-price, and designed for modern visual demands. New upselling options for ECPs.

Learn More
EssilorLuxottica

EssilorLuxottica Creates Scientific Advisory Committee to Cccelerate Next Era of Innovation

EssilorLuxottica forms a new Scientific Advisory Committee of global experts to guide innovation in ophthalmology, AI, audiology, and life sciences.

Read more
MIDO logo

MIDO 2026 Exhibitor List Now Live as “The Lens of Time” Exhibition Debuts

MIDO 2026 unveils its exhibitor list and debuts “The Lens of Time,” with 1,200 exhibitors, new installations, and expanded event programming.

Read more
World Council of Optometry

WCO Announces 2025 Election Results and New Global Leadership

The World Council of Optometry announces its 2025 election results and new leadership appointments, shaping the next phase of global optometric advocacy.

Read more
University Waterloo School of Optometry

WEI 2025: Education, Innovation, and Connection

The WEI Conference returns November 7–9, 2025 at the Hilton Toronto/Markham Suites with over 20 hours of COPE-accredited CE, the Woodruff and Bobier Distinguished Lectures, a strong speaker lineup, and a trade show featuring 30+ exhibitors — including VuePoint IDS at Booth #311.

Read more
Zeiss light 2 lenses

ZEISS Light 2 Facilitates Entry into Progressive and Digital Lenses

ZEISS introduces Light 2 progressive and digital lenses—easy to adapt, mid-price, and designed for modern visual demands. New upselling options for ECPs.

Learn More
EssilorLuxottica

EssilorLuxottica Creates Scientific Advisory Committee to Cccelerate Next Era of Innovation

EssilorLuxottica forms a new Scientific Advisory Committee of global experts to guide innovation in ophthalmology, AI, audiology, and life sciences.

Read more
MIDO logo

MIDO 2026 Exhibitor List Now Live as “The Lens of Time” Exhibition Debuts

MIDO 2026 unveils its exhibitor list and debuts “The Lens of Time,” with 1,200 exhibitors, new installations, and expanded event programming.

Read more
World Council of Optometry

WCO Announces 2025 Election Results and New Global Leadership

The World Council of Optometry announces its 2025 election results and new leadership appointments, shaping the next phase of global optometric advocacy.

Read more
University Waterloo School of Optometry

WEI 2025: Education, Innovation, and Connection

The WEI Conference returns November 7–9, 2025 at the Hilton Toronto/Markham Suites with over 20 hours of COPE-accredited CE, the Woodruff and Bobier Distinguished Lectures, a strong speaker lineup, and a trade show featuring 30+ exhibitors — including VuePoint IDS at Booth #311.

Read more